BR0108823A - Pharmaceutical composition for the treatment of cognitive cerebrovascular disease - Google Patents

Pharmaceutical composition for the treatment of cognitive cerebrovascular disease

Info

Publication number
BR0108823A
BR0108823A BR0108823-8A BR0108823A BR0108823A BR 0108823 A BR0108823 A BR 0108823A BR 0108823 A BR0108823 A BR 0108823A BR 0108823 A BR0108823 A BR 0108823A
Authority
BR
Brazil
Prior art keywords
treatment
pharmaceutical composition
cognitive
cerebrovascular disease
cerebrovascular
Prior art date
Application number
BR0108823-8A
Other languages
Portuguese (pt)
Inventor
Marcelo A Ricci
Silvia Krasuk
Joaquina Faour
Original Assignee
Osmotica Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ARP000107022A external-priority patent/AR027152A1/en
Application filed by Osmotica Corp filed Critical Osmotica Corp
Publication of BR0108823A publication Critical patent/BR0108823A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA PARA O TRATAMENTO DA DOENçA CEREBROVASCULAR COGNITIVA". A invenção refere-se a uma composição farmacêutica que compreende idebenona em combinação sinergística com nimodipina para o tratamento de perturbações cognitivas de origem cerebrovascular"PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COGNITIVE CEREBROVASCULAR DISEASE". The invention relates to a pharmaceutical composition comprising idebenone in synergistic combination with nimodipine for the treatment of cognitive disorders of cerebrovascular origin

BR0108823-8A 2000-12-29 2001-12-21 Pharmaceutical composition for the treatment of cognitive cerebrovascular disease BR0108823A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ARP000107022A AR027152A1 (en) 2000-12-29 2000-12-29 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COGNITIVE CEREBROVASCULAR DISEASE.
US09/828,777 US6458808B1 (en) 2000-12-20 2001-04-09 Pharmaceutical composition for the treatment of cognitive cerebrovascular disease
PCT/CR2001/000005 WO2002053147A1 (en) 2000-12-29 2001-12-21 Pharmaceutical composition for the treatment of cerebrovascular cognitive disease

Publications (1)

Publication Number Publication Date
BR0108823A true BR0108823A (en) 2002-12-10

Family

ID=25590794

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108823-8A BR0108823A (en) 2000-12-29 2001-12-21 Pharmaceutical composition for the treatment of cognitive cerebrovascular disease

Country Status (2)

Country Link
BR (1) BR0108823A (en)
WO (1) WO2002053147A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1727531A1 (en) * 2004-03-12 2006-12-06 EGIS Gyógyszergyár Nyrt Combined pharmaceutical composition for the inhibition of the decline of cognitive functions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788793A1 (en) * 1996-02-01 1997-08-13 Takeda Chemical Industries, Ltd. Idebenone for the treatment of dementia
DE19754573A1 (en) * 1997-12-09 1999-06-10 Bayer Ag Pharmaceutical composition for the treatment of stroke and traumatic brain injury
CZ299429B6 (en) * 1998-07-10 2008-07-23 Novartis Ag Medicament containing combination of valsartan and calcium channel blocker

Also Published As

Publication number Publication date
WO2002053147A1 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
ECSP067043A (en) USEFUL PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
BR0013122A (en) Cyclobenzaprine for treatment of generalized anxiety disorder and cyclobenzaprine compositions
BR9911440A (en) Composition for the prevention and / or treatment of osteoporosis and changes due to menopause syndrome
UY26130A1 (en) COMPOUNDS TO TREAT OBESITY
AR026610A1 (en) A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
BRPI0410503B8 (en) topical composition and use of composition
TW200716208A (en) Modified and immediate release memantine bead formulation
PA8479201A1 (en) DERIVATIVES OF HYDROXY ACID-HYDROXAMIC PIPECOLATE
BR0310099A (en) method for treating dyslipidemia or a disease associated with dyslipidemia
HN2002000275A (en) DERIVATIVES OF 1.8 NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
BR0114410A (en) Combination of a cb1 receptor antagonist and sibutramine, the pharmaceutical compositions containing them and their use for the treatment of obesity
BR0008059A (en) Compositions of valdecoxib
BR0207961A (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases.
BR0008447A (en) Methods of treating mitochondrial disorders
BR0215193A (en) Directly compressible azithromycin formulations
BR9912179A (en) Neuroprotective composition for the prevention and / or treatment of nervous and behavioral changes due to states of anxiety or depression
BRPI0212298B8 (en) pharmaceutical composition comprising gabapentin or an analogue thereof and (alpha)-aminoamide and its analgesic use
BR9914419A (en) Perception improvement therapy
BR0316723A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
BR9916575A (en) Pharmaceutical composition of controlled release with tilidine mesylate as active substance
BRPI0411176A (en) pharmaceutical combination consisting of modafinil and another drug
BR9911917A (en) Compositions comprising gaba and caffeine analogs
ECSP003707A (en) DIAZEPANES
ES2170143T3 (en) COMPOSITIONS THAT INCLUDE HALOFANTRINE IN A SPECIAL FORM.
BRPI0408889A (en) Clusterin use for treatment and / or prevention of peripheral neurological diseases

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 31/122, A61K 31/4422, A61P 25/28, A61P 9/10

Ipc: A61K 31/122 (2006.01), A61K 31/4422 (2006.01), A61

B25A Requested transfer of rights approved

Owner name: OSMOTICA KERESKEDELMI ES SZOLGALGATO KFT (HU)

Free format text: TRANSFERIDO DE: OSMOTICA CORP.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.